Long-term Study With Clevudine

Clinical trial NCT00558818 · COMPLETED

Trial details

NCT number: NCT00558818
Sponsor: Bukwang Pharmaceutical
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2007-06-01
Primary completion: 2011-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.